SEGUDIAB Study: Evaluation of Safety in the Diabetic Patients (SEGUDIAB)
SEGUDIAB Study: Safety in Diabetic Patients. Evaluation of an Educational Program for the Professionals to Improve the Safety in Diabetic Patients
Sponsor: Department of Health, Generalitat de Catalunya
Listed as NCT01087541, this NA trial focuses on Diabetes Mellitus and remains completed. Sponsored by Department of Health, Generalitat de Catalunya, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2023 — Mar 2023 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Department of Health, Generalitat de Catalunya
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
- Fundación Avedis Donabedian
For direct contact, visit the study record on ClinicalTrials.gov .